Jennifer Doudna

In this enlightening conversation, Demis Hassabis, CEO of DeepMind and a pioneer of AI, joins Nobel laureates Sir Paul Nurse, Jennifer Doudna, and John Jumper. They discuss transformative AI technologies like AlphaFold and CRISPR, emphasizing AI's role in revolutionizing scientific discovery. The panel addresses the importance of human creativity and interdisciplinary collaboration in research, while reflecting on the societal implications of advanced AI. A $20 million funding initiative to foster these collaborations is also unveiled, highlighting the future of science.

Jennifer Doudna, a pioneering biochemist and Nobel Prize winner, discusses the future of CRISPR technology. She reveals how her work in precision microbiome editing aims to tackle critical issues like asthma and Alzheimer's. Doudna highlights the innovative integration of CRISPR and metagenomics, presenting a groundbreaking approach to health and environmental challenges. The conversation also covers the exciting potential for reducing methane emissions from livestock, showcasing how science can pave the way for a healthier planet.

Original broadcast date: January 7, 2022. New innovations in gene and stem cell technology have the power to shape ecosystems and even change humanity. This hour, TED speakers share the breakthroughs heralding the next scientific revolution. Guests include biochemist Jennifer Doudna, physicist and biotech entrepreneur Nabiha Saklayen and conservation innovator and biotech entrepreneur Ryan Phelan.TED Radio Hour+ subscribers now get access to bonus episodes, with more ideas from TED speakers and a behind the scenes look with our producers. A Plus subscription also lets you listen to regular episodes (like this one!) without ads. Sign-up at plus.npr.org/ted.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Join biochemist Jennifer Doudna, who pioneered CRISPR technology, and Tom Oxley, a vascular neurosurgeon revolutionizing brain-computer interfaces with his Stentrode implant. Nita Farahani, a legal scholar, advocates for cognitive liberty amidst the rise of neurotechnology. The trio dives into the ethical implications of biotech advancements, from genetic editing to the privacy of our thoughts. They explore how these innovations can transform healthcare, while also stressing the importance of protecting individual rights in an increasingly tech-driven world.

Jennifer Doudna, a renowned biochemist and Nobel Prize winner, discusses her groundbreaking work on CRISPR, the revolutionary gene-editing tool born from pure scientific curiosity. She reflects on the serendipity of scientific discovery and shares personal anecdotes about her journey from chemistry to biology. Doudna delves into the ethical implications of CRISPR, the nuances of genetic transcription, and the transformative potential of gene editing in healthcare and agriculture. Her insights highlight the balance between innovation and responsibility in shaping humanity's future.

In this engaging discussion, guests Catie Cuan, a robot choreographer, and Hugh Herr, an MIT professor and expert in prosthetics, share insights on blending technology with human experience. Anna Maria Coclite, a materials scientist, unveils her groundbreaking work on artificial skin that mimics touch, while Jennifer Doudna reveals the revolutionary potential of CRISPR in health. Together, they explore how advancements in robotics, prosthetics, and genetics can enhance human capabilities and redefine our relationship with technology.

Author Walter Isaacson discusses his recent book "The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race", a gripping account of how Nobel Prize winner Jennifer Doudna and her colleagues launched a revolution that will allow us to cure diseases, fend off viruses, and have healthier babies. Bestselling author of "Steve Jobs" (2011), "Einstein: His Life and Universe" (2007) and more, Walter Isaacson has established himself as the biographer of creativity, innovation, and genius. Einstein was the genius of the revolution in physics, and Steve Jobs was the genius of the revolution in digital technology. We are now on the cusp of a third revolution in science, a revolution in biochemistry that is capable of curing diseases, fending off viruses, and improving the Human species itself. The genius at the center of his newest book "The Code Breaker" is American biochemist Jennifer Doudna, who is considered one of the prime inventors of CRISPR, a system that can edit DNA. Moderated by Leigh Gallagher. Visit YouTube.com/TalksatGoogle to watch the video.  

In this engaging discussion, Dr. Jennifer Doudna, a Nobel Prize-winning pioneer in CRISPR technology, teams up with Dr. Priscilla Chan, a visionary pediatrician and co-founder of the Chan Zuckerberg Initiative. They unveil an inspiring new center dedicated to pediatric CRISPR therapies, sharing how basic science is crucial for tackling rare diseases. They highlight the remarkable story of baby KJ's treatment, advancements in CRISPR for severe combined immunodeficiencies, and a hopeful future for addressing various genetic disorders.

In this engaging discussion, Demis Hassabis, CEO of Google DeepMind, James Manyika from Google, and Nobel laureate Jennifer Doudna explore the game-changing role of AI in scientific research. They highlight how AI tools like AlphaFold are revolutionizing drug discovery and structural biology, enabling breakthroughs in combatting diseases. Doudna shares insights on AI's impact on genetic research, especially in enhancing CRISPR technology. The conversation also touches on the future of computational biology and the data-driven evolution of AI, aiming to tackle global challenges.

Jennifer Doudna, a Nobel laureate and CRISPR co-discoverer, discusses the groundbreaking potential of gene editing to transform medicine, including treatments for diseases like Alzheimer's. Fei-Fei Li, a pioneer in AI, shares insights on the evolution of artificial intelligence, particularly in visual recognition, and its implications for human-machine collaboration. Both guests highlight ethical dilemmas in their fields, emphasizing the need for responsible advancements that enhance human health and agency.